1 results match your criteria: "Vall d'Hebron University Hospital-Barcelona Pubic Health Agency (ASPB)[Affiliation]"
The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.
Expert Rev Neurother
August 2014
Department of Psychiatry, Outpatient Drug Clinic, Vall d'Hebron University Hospital-Barcelona Pubic Health Agency (ASPB), Passeig Vall d'Hebron, 119-129, E-08035 Barcelona, Spain.
Lisdexamfetamine dimesylate (LDX) is a long-acting oral prodrug stimulant. It is inactive until enzymatically hydrolyzed in the blood to active D-amphetamine. The pharmacological action of this compound involves blocking norepinephrine (NE) and dopamine reuptake into presynaptic neurons and promoting the release of NE and dopamine into the extraneuronal space.
View Article and Find Full Text PDF